ASP Isotopes Inc., a Delaware-based company, has entered into a significant agreement with TerraPower, a US nuclear innovation firm, to support the construction of a new uranium enrichment facility. This facility will produce High Assay Low-Enriched Uranium (HALEU) and supply it to TerraPower. Under the loan agreement signed on May 16, 2025, TerraPower will provide conditional financial commitments amounting to $22 million to ASP Isotopes' subsidiary, QLE TP Funding SPE LLC. The loan is guaranteed by ASP Isotopes Inc. and Quantum Leap Energy LLC, with a maturity date set for May 16, 2032. The agreement includes a long-term supply arrangement without minimum purchase requirements, allowing ASP Isotopes to sell excess HALEU to other buyers if TerraPower does not meet certain purchase criteria. The contract also outlines responsibilities for liquidated damages in case of delays, with specific provisions for force majeure events.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。